| __timestamp | Evotec SE | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 8494000000 |
| Thursday, January 1, 2015 | 18343000 | 9046000000 |
| Friday, January 1, 2016 | 18108000 | 9095000000 |
| Sunday, January 1, 2017 | 17614000 | 10554000000 |
| Monday, January 1, 2018 | 35619000 | 10775000000 |
| Tuesday, January 1, 2019 | 58432000 | 11355000000 |
| Wednesday, January 1, 2020 | 63945000 | 12340000000 |
| Friday, January 1, 2021 | 72200000 | 14277000000 |
| Saturday, January 1, 2022 | 76642000 | 14135000000 |
| Sunday, January 1, 2023 | 57519000 | 15048000000 |
| Monday, January 1, 2024 | 17232000000 |
Infusing magic into the data realm
In the ever-evolving world of pharmaceuticals, innovation is the lifeblood that drives progress. Johnson & Johnson, a stalwart in the industry, has consistently outpaced Evotec SE in research and development (R&D) investments over the past decade. From 2014 to 2023, Johnson & Johnson's R&D expenses have surged by approximately 77%, peaking at $15 billion in 2023. In contrast, Evotec SE, a dynamic player in the biotech sector, has seen its R&D spending grow by over 360%, reaching nearly $77 million in 2022. Despite the stark difference in absolute numbers, Evotec's growth rate is impressive, reflecting its commitment to innovation. This comparison highlights the diverse strategies of a pharmaceutical giant and a biotech innovator, each striving to lead in their respective fields. As the industry continues to evolve, these investments will play a crucial role in shaping the future of healthcare.
Johnson & Johnson vs AstraZeneca PLC: Strategic Focus on R&D Spending
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Johnson & Johnson vs Gilead Sciences, Inc.
Analyzing R&D Budgets: Johnson & Johnson vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Amgen Inc. vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Evotec SE
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Evotec SE
Research and Development Expenses Breakdown: Viatris Inc. vs Evotec SE
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Supernus Pharmaceuticals, Inc. and Evotec SE
Taro Pharmaceutical Industries Ltd. vs Evotec SE: Strategic Focus on R&D Spending